The IL-1αMPs also triggered the expansion and activation of CD4 + T cells, cytotoxic CD8 + T cells and natural killer (NK) cells in addition to DCs, suggesting the induction of a broad anti-tumor immune response [19]. The gene discussed is CD8A; the disease is neoplasm.